Turn Therapeutics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
250 N Westlake Blvd, Westlake Village, C...Phone Number
(818) 564-4011Website
www.turntherapeutics.comRevenue
-Stock Symbol
TTRXIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Turn Therapeutics
Turn Therapeutics is a concept-to-approval research and development organization focused on novel, best in class products for infection control, skin disease, and wound care. The company's proprietary technologies are used every day by world-leading healthcare institutions to care for a variety of skin and wound conditions.Explore more
Turn Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Turn Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Turn Therapeutics had a recent Job posting/layoffs
Check out if Turn Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Turn Therapeutics
Earning: See what the market has to say on Turn Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Turn Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Turn Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Turn Therapeutics launches new products
Turn Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Turn Therapeutics
Compare insights from companies similar to Turn Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Turn Therapeutics
1-10
Public
$100M
2015
Zuraiz ChaudharyChief Accounting Officer & Vice President, Finance
Company Profile Activity
Activity Insights
Turn Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Turn Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Turn Therapeutics.
Turn Therapeutics financials insights
Gather financial insights about Turn Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$75M
2026
Debt
$25M
Turn Therapeutics Tech Stack
A closer look at the technologies used by Turn Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Funding
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
Executive Move
Executive Moves, Board of Directors
Turn Therapeutics News & Media
Turn Therapeutics Appoints Martin Dewhurst to its Board of Directors
Mr. Dewhurst Brings Over 30 Years of Life Sciences and M&A Experience to the Board, Aligning with the Company’s Strategic Long-Term Goals for Growth and Expansion Mr. Dewhurst Brings Over 30 Years of Life Sciences and M&A Experience to the Board, Aligning with the Company’s Strategic Long-Term Goals for Growth and ExpansionTurn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
Successfully began trading on NASDAQ under ticker TTRX on October 8, 2025Turn Therapeutics’ GX-03 Technology Named as One of “Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine
Turn’s Topical IL36/IL31 Inhibitor Named Alongside Other Phase 2 & 3 Candidates from Amgen, Sanofi, Leo Pharma, Apogee Therapeutics, and Nektar Therapeutics Turn’s Topical IL36/IL31 Inhibitor Named Alongside Other Phase 2 & 3 Candidates from Amgen, Sanofi, Leo Pharma, Apogee Therapeutics, and Nektar TherapeuticsTurn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications
LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing dermatologic, advanced wound, and infectious disease therapies, today announced the appointment of Andrew Scott as Vice President of Corporate Communications. In this new role, Mr. Scott will oversee investor relations, capital markets strategy, and corporate communications, while supporting the Company’s licensing and partnership initiatives.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Turn Therapeutics
Sign Up For FreeTo access detailed company insights
Turn Therapeutics is a concept-to-approval research and development organization focused on novel, best in class products for infection control, skin disease, and wound care. The company's proprietary technologies are used every day by world-leading healthcare institutions to care for a variety of skin and wound conditions.... Read More
